retatrutide fat loss clinical trial results Biggest obesity news 🚨 TRIUMPH-1 are here: Retatrutide's phase 3 showed up to 28% average weight over 80 weeks — with nearly half of patients losing over 30% of Reta clinical trial data &

Some specific bacterial strains like Lactobacillus acidophilus have been shown to promote GLP-1 secretion, and their depletion in Hashimoto's patients may partially explain why weight management becomes so challenging even before considering thyroid hormone levels

This systems-level approach has contributed to Retatrutide becoming one of the most actively investigated compounds in contemporary metabolic peptide research

If you are someone who is impacted by MCAS you may want to consider discussing this study with your prescribing practitioner

Wilding J et al

The evidence for split dosing with retatrutide specifically is limited since clinical trials used once-weekly dosing exclusively

It means retatrutide does not just reduce calorie intake through appetite suppression, it also increases calorie burning